Genflow Biosciences PLC Announces Administrative Approval of Grant & 2026 Priorities
Accessnewswire·2026-01-28 07:00
Core Viewpoint - The announcement contains information classified as inside information under the Market Abuse Regulation, indicating its significance for market participants [1] Group 1 - The company asserts that the information is relevant to UK domestic law as per the European Union (Withdrawal) Act 2018 [1]